National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 2,281 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died



Case Details (Sorted by Age)

This is page 8 out of 229

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17   next


VAERS ID: 1016989 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-15
Onset:2021-01-21
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, Pneumonitis, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Interstitial lung disease (narrow), Eosinophilic pneumonia (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-23
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ADCAL D3; AMLODIPINE; ATORVASTATIN; EDOXABAN; LANSOPRAZOLE; LOSARTAN; PARACETAMOL; SALBUTAMOL; TRIMIPRAMINE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Suspected COVID-19
Allergies:
Diagnostic Lab Data: Test Date: 20210121; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021115665

Write-up: Pneumonitis; Drug ineffective; Covid-19; This is a spontaneous report from a contactable healthcare professional, received from the Regulatory authority report number GB-MHRA-WEBCOVID-202102031728405430, Safety Report Unique Identifier GB-MHRA-ADR 24694509. A 80-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 15Jan2021 at single dose for COVID-19 immunization, via an unspecified route of administration. Medical history included suspected covid-19 on 17Jan2021. Concomitant medication included calcium carbonate, colecalciferol (ADCAL D3), amlodipine, atorvastatin, edoxaban, lansoprazole, losartan, paracetamol, salbutamol, trimipramine. The patient experienced pneumonitis on 21Jan2021 and the sars-cov-2 test was positive on 21Jan2021. The patient died on 23Jan2021. It was not reported if an autopsy was performed. Patient was not enrolled in clinical trial. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Pneumonitis


VAERS ID: 1029877 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-05
Onset:2021-01-07
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-02-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-01
   Days after onset: 25
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210107; Test Name: SARS-CoV-2 PCR test; Test Result: Positive ; Test Date: 20210125; Test Name: SARS-CoV-2 PCR test; Test Result: Positive
CDC Split Type: DEPFIZER INC2021134977

Write-up: bothsided pneumonia in the presence of COVID-19 infection/positive PCR test on COVID-19; bothsided pneumonia in the presence of COVID-19 infection/positive PCR test on COVID-19; This is a spontaneous report from a contactable physician by Pfizer from BIONTECH. An 82-year-old female patient received the first dose of BNT162B2 (COMIRNATY), via an unspecified route of administration on 05Jan2021 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient was vaccinated with 1 first dose on 05Jan2021. The vaccines have not been administered before. The patient had positive PCR test on COVID-19 on 07Jan2021. On 19Jan2021, the patient had progressive worsening of general condition, bedridden, very weak, nutrition (food and drink) has to be supported and served, no cough, no fever. On 25Jan2021, hospitalization with further worsening of general condition and in soporous state. Positive PCR Test on COVID-19 on 25Jan2019. Treatment in hospital from 25Jan2021 to 27Jan2021, Diagnosis: bothsided pneumonia, epicrisis available. On 28Jan2021, the patient had further worsening of general condition, very week, sopor, as per relatives'' wish palliative care initiation. The patient experienced bothsided pneumonia in the presence of COVID-19 infection, firstly diagnosed on 25Jan2021. The diagnoses are confirmed as per hospital epicrisis. The vaccine has not been administered again. The patient died on 01Feb2021. It was not reported if an autopsy was performed. Without any relation to COMINARTY has lead to a prophylactic hospitalization and treatment. A causal relation between course of disease and vaccination is not given. Information about lot/batch number has been requested.; Sender''s Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported positive PCR test on COVID-19 based on the known safety profile. However the short duration of 2 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.; Reported Cause(s) of Death: bothsided pneumonia in the presence of COVID-19 infection/positive PCR test on COVID-19; bothsided pneumonia in the presence of COVID-19 infection/positive PCR test on COVID-19


VAERS ID: 1029878 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-05
Onset:2021-01-20
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-02-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Body temperature, COVID-19, Confusional state, Cyanosis, Drug ineffective, Nasopharyngitis, Oxygen saturation, Oxygen saturation decreased, Respiratory failure, Respiratory tract infection, SARS-CoV-2 test
SMQs:, Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Dementia (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (broad), Respiratory failure (narrow), Hypoglycaemia (broad), Infective pneumonia (broad), Hypokalaemia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-01-27
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210127; Test Name: body temperature; Result Unstructured Data: Test Result:38.0 Centigrade; Test Date: 20210126; Test Name: oxygen saturation; Test Result: 81 %; Test Date: 20210125; Test Name: COVID PCR test; Result Unstructured Data: Test Result:positive
CDC Split Type: DEPFIZER INC2021135047

Write-up: oxygen saturation 81%; cold; livid discoloration of acra; respiratory infection with respiratory insufficiency; respiratory infection with respiratory insufficiency; slightly confused; very weak; COVID-19 PCR test positive; COVID-19 PCR test positive; This is a spontaneous report from a contactable physician via local license partner. A 85-year-old male patient received first dose of BNT162B2 (COMIRNATY) on 05Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had respiratory infection with respiratory insufficiency on 20Jan2021. On 20Jan2021 patient was in reduced general condition, slightly confused, very weak, no cough, no fever. On 25Jan2021 positive PCR test (throat swab). On 26Jan2021 very bad general condition, confused, cold and livid discoloration of acra, oxygen saturation 81%. Palliative therapy with alleviation of symptoms after consultation of his daughter. On 27Jan2021 further deterioration of general condition, temperature 38 degrees Celsius, "Exitus letalis" at 5:10 p.m. All events except COVID-19 PCR test positive required outpatient treatment, hospitalization and was life-threatening. The patient died on 27Jan2021 at 5:10 p.m due to all events except COVID-19 PCR test positive. The outcome of COVID-19 PCR test positive was unknown. Information on the lot/batch number has been requested.; Sender''s Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 and suspected LOE. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine is given and due to only the first dose was administered. Based on available information, a possible contributory role of BNT162B2 vaccine cannot be excluded for the other reported events due to temporal relationship Additional information is needed to better assess the case, including complete medical history, diagnostics including chest x-ray and autopsy results, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate. ; Reported Cause(s) of Death: respiratory infection with respiratory insufficiency; respiratory infection with respiratory insufficiency; slightly confused; very weak; oxygen saturation 81%; cold; livid discoloration of acra


VAERS ID: 1035119 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-14
Onset:2021-01-26
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-02-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6796 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Atrial fibrillation, Body temperature, COVID-19, Computerised tomogram, Drug ineffective, Heart rate, Motor dysfunction, Neurological examination, Oxygen saturation, Polymerase chain reaction
SMQs:, Lack of efficacy/effect (narrow), Peripheral neuropathy (broad), Supraventricular tachyarrhythmias (narrow), Akathisia (broad), Dyskinesia (broad), Dystonia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-28
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anterior cruciate ligament tear (Ligamentoplasty of the right anterior cruciate ligament); Appendicectomy; Blindness, one eye (blindness of the right eye); Calcific pancreatitis; Cataract (right) (probable cataract of the right eye); Chronic alcoholism (chronic alcoholism, currently weaned); Diabetes; Humerus fracture (Right humeral fracture with braces); Hypertension arterial; Hyperthyroidism; Peripheral obliterative arteriopathy; Tetraparesis (Appearance of a motor deficit in the 2 upper limbs); Transmetatarsal amputation (trans metatarsal amputation of the right foot); Ulcerative gastritis
Allergies:
Diagnostic Lab Data: Test Date: 20210114; Test Name: TA; Result Unstructured Data: Test Result:128/73; Test Date: 20210114; Test Name: TA; Result Unstructured Data: Test Result:12/7; Test Date: 20210114; Test Name: body temperature; Result Unstructured Data: Test Result:36.7 Centigrade; Test Date: 20210114; Test Name: body temperature; Result Unstructured Data: Test Result:36.1 Centigrade; Test Date: 20180827; Test Name: CT SCAN; Result Unstructured Data: Test Result:found diffuse encephalic atrophy with old left fro; Comments: found diffuse encephalic atrophy with old left frontal ischemic sequelae + per-ventricular leucoaraiosis.; Test Date: 20210114; Test Name: pulse rate; Result Unstructured Data: Test Result:60; Test Date: 20210114; Test Name: pulse rate; Result Unstructured Data: Test Result:78; Test Date: 20180827; Test Name: MOTOR DEFICIT; Result Unstructured Data: Test Result:Appearance of a motor deficit in the 2 upper limbs; Comments: Appearance of a motor deficit in the 2 upper limbs making it difficult to take meals alone from the summer of 2018; Test Date: 20180827; Test Name: Neurological exam; Result Unstructured Data: Test Result:had highlighted a tetraparesis around 4/5 greater; Comments: had highlighted a tetraparesis around 4/5 greater with a more marked deficit in the upper right limb, probably related to humeral surgery in 2013, associated with advanced peripheral neuropathy, related to diabetes and cognitive impairment with notable dysexecutive syndrome; Test Date: 20210114; Test Name: oxygen saturation; Result Unstructured Data: Test Result:95; Test Date: 20210114; Test Name: oxygen saturation; Result Unstructured Data: Test Result:97; Test Date: 20210114; Test Name: PCR; Result Unstructured Data: Test Result:COVID +
CDC Split Type: FRPFIZER INC2021134701

Write-up: positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable other health professional downloaded from the regulatory authority FR-AFSSAPS-SE20210154. This reporter reported similar events for two patients. This is the second of two reports. A 68-year-old male patient received first dose of bnt162b2 (COMIRNATY, lot no. EJ6796), intramuscularly in left arm on 14Jan2021 at single dose for covid-19 immunization. Medical history included cataract (probable cataract of the right eye), Anterior cruciate ligament tear (Ligamentoplasty of the right anterior cruciate ligament), ulcerative gastritis, peripheral arterial occlusive disease, Transmetatarsal amputation (trans metatarsal amputation of the right foot), pancreatitis chronic, hyperthyroidism, Hypertension arterial, diabetes mellitus, appendicectomy, Humerus fracture, Blindness, one eye, Tetraparesis all from an unknown date and unknown if ongoing; Chronic alcoholism from an unknown date not ongoing. Background included: diabetes complicated by transmetatarsal amputation of the right foot under insulin; AOMI; HTA (hypertension); probable cataract of the right eye with blindness of the right eye; Right humeral fracture with braces; Ligamentoplasty of the right anterior cruciate ligament, appendectomy; Calcifying pancreatitis; Biological hyperthyroidism; Ulcerated gastritis; Insane syndrome: CT scan of 27Aug18 which found diffuse encephalic atrophy with old left frontal ischemic sequelae + per-ventricular leucoaraiosis. Appearance of a motor deficit in the 2 upper limbs making it difficult to take meals alone from the summer of 2018. The neurological examination had highlighted a tetraparesis around 4/5 greater with a more marked deficit in the upper right limb, probably related to humeral surgery in 2013, associated with advanced peripheral neuropathy, related to diabetes and cognitive impairment with notable dysexecutive syndrome. Patient institutionalized around the age of 60 in a context of chronic alcoholism, currently weaned. Treatment in 2019 included: insulin glargine (ABASAGLAR) 100: 10-0-0; alprazolam 0.5: 0.5-0.5-1; amlodipine 5: 1-0-0; rosuvastatin 5: 0-0-1; boric acid; sodium borate (DACRYOSERUM) 1-0-1; betamethasone dipropionate; calcipotriol (DAIVOBET) 50: 1-0-1; econazole 1-0-1; latanoprost (MONOPROST) 0-0-1; clopidogrel 0-1-0; retinol;tocopherol (VITAMIN A) 0-0-1. The patient''s concomitant medications were not reported. The patient experienced covid-19 (death) on 26Jan2021, Symptoms: dyspnea, fever, asthenia =$g put on O2. The patient underwent lab tests and procedures which included computerised tomogram: found diffuse encephalic atrophy with old left frontal ischemic sequelae + per-ventricular leucoaraiosis on 27Aug2018, motor dysfunction: Appearance of a motor deficit in the 2 upper limbs making it difficult to take meals alone from the summer of 2018 on 27Aug2018, neurological examination: had highlighted a tetraparesis around 4/5 greater with a more marked deficit in the upper right limb, probably related to humeral surgery in 2013, associated with advanced peripheral neuropathy, related to diabetes and cognitive impairment with notable dysexecutive syndrome on 27Aug2018, Constant monitoring before injection on 14Jan2021: pulse: 60; TA (Atrial fibrillation): 128/73; Saturation: 95; Temperature: 36.7. Constant monitoring 15 minutes after injection on 14Jan2021: pulse: 78; TA: 12/7; Saturation: 97; Temperature: 36.1. PCR (polymerase chain reaction): COVID positive on 14Jan2021. The patient died on 28Jan2021. It was not reported if an autopsy was performed.; Sender''s Comments: Linked Report(s) : FR-PFIZER INC-2021134697 different patient, same cluster of reports; Reported Cause(s) of Death: positive COVID-19 test with symptoms; positive COVID-19 test with symptoms


VAERS ID: 1035120 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-14
Onset:2021-01-18
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-02-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6796 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure measurement, Body temperature, COVID-19, Drug ineffective, Heart rate, Oxygen saturation, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-23
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Alzheimer''s disease; Anxiodepressive syndrome; Carotid endarterectomy (1988 Internal carotid endariectomy); Cataract; Cataract operation; Hypothyroidism; Senile macular degeneration
Allergies:
Diagnostic Lab Data: Test Name: Blood pressure; Result Unstructured Data: Test Result:115/10; Comments: Constant monitoring before injection; Test Name: Blood pressure; Result Unstructured Data: Test Result:11/8; Comments: Constant monitoring 15 minutes after injection; Test Name: temperature; Result Unstructured Data: Test Result:36.5; Comments: Constant monitoring before injection; Test Name: temperature; Result Unstructured Data: Test Result:36.2; Comments: Constant monitoring 15 minutes after injection; Test Name: Pulse rate; Result Unstructured Data: Test Result:80; Comments: Constant monitoring before injection; Test Name: Pulse rate; Result Unstructured Data: Test Result:84; Comments: Constant monitoring 15 minutes after injection; Test Name: saturation; Result Unstructured Data: Test Result:91; Comments: Constant monitoring before injection; Test Name: saturation; Result Unstructured Data: Test Result:93; Comments: Constant monitoring 15 minutes after injection; Test Date: 20210118; Test Name: PCR SARS-COV 2; Test Result: Positive
CDC Split Type: FRPFIZER INC2021134697

Write-up: positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable other HCP from the Medicines Agency (MA) Regulatory authority WEB FR-AFSSAPS-SE20210161. This other HCP reported similar events for 2 patients. This is the first of two reports. A 78-year-old female patient received first dose of bnt162b2 (COMIRNATY, Lot#EJ6796), intramuscularly on 14Jan2021 at single dose, left arm for covid-19 immunisation. Medical history included cataract surgery, senile macular degeneration, Internal carotid endarterectomy from 1988, Alzheimer''s disease from 2015, hypothyroidism, Anxiodepressive syndrome, Catarct surgery. The patient''s concomitant medications were not reported. Treatment in Dec2020 included acetylsalicylate lysine (KARDEGIC) 75mg 1 sachet at noon; paroxetine 20 mg 1 + 0.5 in the morning; mianserine 10mg 2 tablets if needed; diazepam 10 drops at bedtime; olanzapine 5mg 0.5 -0 -0.5; zopiclone 7.5mg 0-0-1; levothyroxine sodium (LEVOTHYROX) 100?g 1-0-0; calcium D3: 500mg 1 sachet in the morning. The patient experienced covid-19 (PCR COVID +) on 18Jan2021. The event was serious as death. Symptoms reported as dyspnea, fever, fatigue. The patient was put on O2. The patient underwent lab tests and procedures which included blood pressure (Constant monitoring before injection): 115/10, blood pressure (Constant monitoring 15 minutes after injection): 11/8, body temperature(Constant monitoring before injection): 36.5, body temperature (Constant monitoring 15 minutes after injection): 36.2, pulse rate(Constant monitoring before injection): 80, pulse rate(Constant monitoring 15 minutes after injection): 84, oxygen saturation(Constant monitoring before injection): 91, oxygen saturation(Constant monitoring 15 minutes after injection): 93, PCR covid + on 18Jan2021. The patient died on 23Jan2021. It was not reported if an autopsy was performed. ; Sender''s Comments: Linked Report(s) : FR-PFIZER INC-2021134701 different patient, same cluster of reports; Reported Cause(s) of Death: COVID-19 infection


VAERS ID: 1035136 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-12
Onset:2021-01-22
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-02-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Alanine aminotransferase, Basophil count, Basophil percentage, Blood albumin, Blood alkaline phosphatase, Blood bilirubin, Blood creatinine, Blood potassium, Blood sodium, COVID-19, Death, Drug ineffective, Eosinophil count, Eosinophil percentage, Full blood count, Glomerular filtration rate, Haematocrit, Haemoglobin, Investigation, Liver function test, Lymphocyte count, Lymphocyte percentage, Mean cell haemoglobin, Mean cell volume, Mean platelet volume, Medical observation, Monocyte count, Monocyte percentage, Neutrophil count, Neutrophil percentage, Ophthalmological examination, Platelet count, Red blood cell analysis, Red blood cell count, Red cell distribution width, Renal function test, SARS-CoV-2 test, White blood cell count
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: DOXYCYCLINE; SALBUTAMOL
Current Illness: Cough; Ex-smoker
Preexisting Conditions: Medical History/Concurrent Conditions: Cough
Allergies:
Diagnostic Lab Data: Test Date: 20201125; Test Name: Alanine aminotransferase; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Basophil count; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: basophils percentage; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Blood albumin; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Blood alkaline phosphatase; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Blood bilirubin; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Blood creatinine; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Blood potassium; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Blood sodium; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Eosinophil count; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: percentage eosinophils; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Full blood count; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Glomerular filtration rate; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Haematocrit; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Haemoglobin; Result Unstructured Data: Test Result:unknown results; Test Date: 20200710; Test Name: Investigation; Result Unstructured Data: Test Result:Diabetes Year of Care annual review; Test Date: 20201125; Test Name: Liver function test; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Lymphocyte count; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: percentage lymphocytes; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Mean cell haemoglobin; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Mean cell volume; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: mean platelet volume; Result Unstructured Data: Test Result:unknown results; Test Date: 20200326; Test Name: Medical observation; Result Unstructured Data: Test Result:Seen in respiratory clinic; Test Date: 20201125; Test Name: Monocyte count; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: percentage monocytes; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Neutrophil count; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: percentage neutrophils; Result Unstructured Data: Test Result:unknown results; Test Date: 20201211; Test Name: Ophthalmological examination; Result Unstructured Data: Test Result:Left/right eye no maculopathy, left/right eye; Comments: Left/right eye no maculopathy, left/right eye background diabetic retinopathy (disorder); Test Date: 20201125; Test Name: Platelet count; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Red blood cell analysis; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Red blood cell count; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: red blood cell distribution; Result Unstructured Data: Test Result:unknown results; Test Date: 20201125; Test Name: Renal function test; Result Unstructured Data: Test Result:unknown results; Comments: renal profile; Test Date: 20210122; Test Name: COVID-19 virus test; Test Result: Positive ; Test Date: 20201125; Test Name: White blood cell count; Result Unstructured Data: Test Result:unknown results
CDC Split Type: GBPFIZER INC2021137332

Write-up: Death; COVID-19 confirmed by laboratory test; COVID-19 confirmed by laboratory test; This is a spontaneous report received from a contactable physician by Pfizer from the Medicines and Healthcare products Regulatory Agency (MHRA). The regulatory authority report number is GB-MHRA-EMIS-8379-9a7f5014-3aa5-4bba-81ac-291254a2ed39. Safety unique identifier GB-MHRA-ADR 24706554. A 79-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscularly on 12Jan2021 at single dose for COVID-19 immunization. Medical history included cough from 04Jan2021 to 02Feb2021, ex-tobacco user from 16Jun2020 and ongoing, cough from 12Mar2020 and ongoing. Concomitant medication included doxycycline from 04Jan2021 for cough, salbutamol from 04Jan2021 for cough. The patient previously received influenza vaccine (INFLUENZA VIRUS) on 25Sep2020. The patient experienced death (medically significant) on an unspecified date, got COVID $g 10 days post dose (medically significant) on 22Jan2021. Event details: COVID-19 confirmed by laboratory test. Got COVID $g 10 days post dose. 29/01/2021: Death notification from hospital. 02/02/2021: Patient died in hospital (pending clarification). The patient underwent lab tests and procedures which included COVID-19 virus test: positive on 22Jan2021, alanine aminotransferase/ basophil count/ basophil percentage/ blood albumin/ blood alkaline phosphatase/ blood bilirubin/ blood creatinine/ blood potassium/blood sodium/ eosinophil count/ eosinophil percentage/ full blood count/ glomerular filtration rate/ haematocrit/ haemoglobin/ Liver function test/Lymphocyte count/ percentage lymphocytes/ Mean cell haemoglobin/ Mean cell volume/ mean platelet volume/ Monocyte count/percentage monocytes/ Neutrophil count/ percentage neutrophils/ Platelet count/ Red blood cell analysis/ Red blood cell count/ red blood cell distribution/ Renal function test (renal profile)/ White blood cell count, all on 25Nov2020 with unknown result, investigation: Diabetes Year of Care annual review on 10Jul2020, Medical observation: Seen in respiratory clinic on 26Mar2020, Ophthalmological examination: Left/right eye no maculopathy, left/right eye background diabetic retinopathy (disorder) on 11Dec2020. The patient died on an unspecified date (pending clarification). It was not reported if an autopsy was performed. The outcome of the event death was fatal, of the other event was not recovered. No follow-up attempts possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Death


VAERS ID: 1035310 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-06
Onset:2021-01-10
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-02-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, Lower respiratory tract infection, SARS-CoV-2 test, Seizure
SMQs:, Lack of efficacy/effect (narrow), Systemic lupus erythematosus (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-03
   Days after onset: 24
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: PREDNISOLONE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation; Chest infection; CVA; Hypertension; Comments: Patient has not had symptoms associated with COVID-19 Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Date: 20210120; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021137102

Write-up: Seizure; SARS-CoV-2 infection; SARS-CoV-2 infection; Chest infection; This is a spontaneous report from a contactable other healthcare professional. This is a report received from the RA. Regulatory authority report number: GB-MHRA-WEBCOVID-202102062019418600, Safety Report Unique Identifier GB-MHRA-ADR 24714675. An 85-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 06Jan2021 at single dose for COVID-19 immunization. Medical history included lower respiratory tract infection, hypertension, cerebrovascular accident and atrial fibrillation unknown if ongoing. Patient had not had symptoms associated with COVID-19. Patient was not enrolled in clinical trial. Concomitant medication included prednisolone. The patient experienced SARS-CoV-2 infection on 20Jan2021, chest infection on 10Jan2021, seizure on 02Feb2021. SARS-CoV-2 infection, chest infection and seizure. Length of being unwell after the vaccination, not to put finger on. Then chest infection treated with antibiotics and prednisolone. Had seizure like episode before completing those medications. Passed away the day after the episode. The patient underwent lab tests and procedures which included COVID-19 virus test: yes - positive covid-19 test on 20Jan2021. The patient died on 03Feb2021 with SARS-CoV-2 infection as cause of death. The outcome of rest events was unknown. It was unknown if an autopsy was performed. No follow-up attempts possible; information regarding batch/lot cannot be obtained; No further information expected.; Reported Cause(s) of Death: SARS-CoV-2 infection; SARS-CoV-2 infection


VAERS ID: 1035311 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-30
Onset:2021-01-02
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-02-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Arthralgia, C-reactive protein, COVID-19, Delusion, Drug ineffective, Gastric haemorrhage, Myalgia, SARS-CoV-2 test
SMQs:, Rhabdomyolysis/myopathy (broad), Lack of efficacy/effect (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Dementia (broad), Gastrointestinal haemorrhage (narrow), Psychosis and psychotic disorders (narrow), Noninfectious encephalopathy/delirium (broad), Eosinophilic pneumonia (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-21
   Days after onset: 19
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ATENOLOL; FUROSEMIDE; ISOSORBIDE; LANSOPRAZOLE; PREDNISONE; SPIRONOLACTONE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Function kidney decreased; Giant cell arteritis; Heart disease, unspecified; Comments: Patient has not had symptoms associated with COVID-19 Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Name: C-reactive protein; Result Unstructured Data: Test Result:over 400; Test Date: 20210114; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Positive
CDC Split Type: GBPFIZER INC2021143624

Write-up: Gastric bleeding; joint pain; Myalgia; Delusion; Whilst in hospital he caught Covid; SARS-CoV-2 infection; This is a spontaneous report received from a contactable consumer by Pfizer from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202102080904506790. Safety unique identifier GB-MHRA-ADR 24718838. An 87-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose on 30Dec2020 for covid-19 immunisation. Medical history included giant cell arteritis, cardiac disorder, renal impairment. Concomitant medication included atenolol, furosemide, isosorbide, lansoprazole. The patient experienced gastric bleeding on 02Jan2021 with fatal outcome on 21Jan2021, whilst in hospital he caught Covid on 15Jan2021 (as reported) with outcome of not recovered, joint pain on an unspecified date with outcome of unknown, myalgia on an unspecified date with outcome of unknown, delusion on an unspecified date with outcome of not recovered. The patient underwent lab tests and procedures which included c-reactive protein: over 400 on an unspecified date, sars-cov-2 test: positive on 14Jan2021 (as reported). The patient died on 21Jan2021. It was not reported if an autopsy was performed. The patient had not had symptoms associated with COVID-19. The patient was not enrolled in a clinical trial. The reporter stated that "My father got very unwell 3 days after he had the vaccine, he became bed bound, his symptoms got so bad he had a gastric bleed that they could not control, so he was hospitalised, his C-reactive protein inflammatory markers went up to over 400 (should be below 8) he became delusional and was screaming in pain from muscle and joint pain. Whilst in hospital he caught Covid and we lost him NOT from Covid but from the effects of the vaccine, He died with covid and not of Covid. His symptoms were devastating from the Jab and then it was a domino effect from there on". No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Gastric haemorrhage


VAERS ID: 1037310 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:2021-01-22
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021160947

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the first of thirteen reports. A patient of unspecified age and gender started to receive bnt162b2 (COMIRNATY, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at single dose for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 22Jan2021, the physician reported an outbreak of covid-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on 22Jan2021 with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: The association between the event lack of effect (fatal COVID19) with COMIRNATY use can not be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : BE-PFIZER INC-2021166347 Same reporter/product/event, different patient;BE-PFIZER INC-2021166343 Same reporter/product/event, different patient;BE-PFIZER INC-2021166348 Same reporter/product/event, different patient;BE-PFIZER INC-2021166349 Same reporter/product/event, different patient;BE-PFIZER INC-2021166346 Same reporter/product/event, different patient;BE-PFIZER INC-2021166352 Same reporter/product/event, different patient;BE-PFIZER INC-2021166345 Same reporter/product/event, different patient;BE-PFIZER INC-2021166342 Same reporter/product/event, different patient;BE-PFIZER INC-2021166344 Same reporter/product/event, different patient;BE-PFIZER INC-2021166353 Same reporter/product/event, different patient;BE-PFIZER INC-2021166351 Same reporter/product/event, different patient; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome


VAERS ID: 1037311 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-11
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021166342

Write-up: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; This is a spontaneous report from a contactable physician. This physician reported similar events for thirteen patients. This is the second of thirteen reports. A patient of unspecified age and gender received BNT162B2 (COMIRNATY, lot number and expiration date not reported), via an unspecified route of administration on 11Jan2021 at single dose for COVID-19 immunisation. Patient medical history and concomitant medical history were not reported. On 22Jan2021, the physician reported an outbreak of covid-19 infection in the retirement home where the physician was working. It was further reported that the contamination spread to 34 residents and 13 deaths to be mourned. The patient experienced COVID-19 on an unspecified date with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. Follow-up attempts are not possible. No further information is expected. Information on lot number cannot be obtained.; Sender''s Comments: The association between the event lack of effect (COVID-19) with COMIRNATY use can not be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : BE-PFIZER INC-2021160947 Same reporter/product/event, different patient; Reported Cause(s) of Death: Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome; Contamination spread to 34 residents and 13 deaths to be mourned / patient had COVID-19 with fatal outcome


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=8&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166